Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01848899

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
  • Guerbet Registry lists this organization as a collaborator
  • NYU Langone Health Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01848899
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01848899. Randomized; single masking. Start 2013-02 (registry gives no type); primary completion 2013-11 (actual). Results posted on 2016-04-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
Intervention (Drug)
Iodixanol
Intervention (Drug)
Ioxaglate
Intervention (Drug)
Bivalirudin
Lead sponsor
NYU Langone Health (class: other)
Collaborator
Guerbet (class: industry)

Record details

Record id
cardio:ct-nct01848899
Content hash
aeef6405c3e7daf1e5879eafe7a2484f2971e86b1c15a1cc6a3a153dfb3bfa5b